Ballentine Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Sell |
6,625
-19
| -0.3% | -$988 | 0.01% | 627 |
|
|
2025
Q1 | $424K | Buy |
6,644
+160
| +2% | +$10.2K | 0.01% | 501 |
|
|
2024
Q4 | $310K | Buy |
6,484
+46
| +0.7% | +$2.2K | 0.01% | 590 |
|
|
2024
Q3 | $369K | Buy |
6,438
+19
| +0.3% | +$1.09K | 0.01% | 515 |
|
|
2024
Q2 | $336K | Buy |
6,419
+129
| +2% | +$6.75K | 0.01% | 524 |
|
|
2024
Q1 | $256K | Sell |
6,290
-100
| -2% | -$4.07K | ﹤0.01% | 595 |
|
|
2023
Q4 | $236K | Buy |
6,390
+145
| +2% | +$5.36K | ﹤0.01% | 581 |
|
|
2023
Q3 | $239K | Buy |
6,245
+89
| +1% | +$3.4K | 0.01% | 499 |
|
|
2023
Q2 | $222K | Buy |
+6,156
| New | +$222K | 0.01% | 524 |
|